These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9350450)

  • 1. Immune mechanisms leading to type 1 insulin-dependent diabetes mellitus.
    Boitard C; Timsit J; Larger E; Dubois D
    Horm Res; 1997; 48 Suppl 4():58-63. PubMed ID: 9350450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stages of type 1A diabetes: 2005.
    Gianani R; Eisenbarth GS
    Immunol Rev; 2005 Apr; 204():232-49. PubMed ID: 15790362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of insulitis and diabetes in B cell-deficient NOD mice.
    Yang M; Charlton B; Gautam AM
    J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.
    Robles DT; Eisenbarth GS; Dailey NJ; Peterson LB; Wicker LS
    Diabetes; 2003 Mar; 52(3):882-6. PubMed ID: 12606534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and pathogenic basis of autoimmune diabetes in NOD mice.
    Serreze DV; Leiter EH
    Curr Opin Immunol; 1994 Dec; 6(6):900-6. PubMed ID: 7710714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherent beta-cell dysfunction induced by transgenic expression of allogeneic major histocompatibility complex class I antigen in islet cells.
    Mandel TE; Allison J; Campbell IL; Koulmanda M; Malcolm L; Cutri A; Miller JF
    Autoimmunity; 1991; 9(1):47-53. PubMed ID: 1669846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin autoimmunity: immunogenetics/immunopathogenesis of type 1A diabetes.
    Eisenbarth GS
    Ann N Y Acad Sci; 2003 Nov; 1005():109-18. PubMed ID: 14679045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus.
    Scherbaum WA; Seissler J
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():88-94. PubMed ID: 8839261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
    O'Kell AL; Wasserfall C; Catchpole B; Davison LJ; Hess RS; Kushner JA; Atkinson MA
    Diabetes; 2017 Jun; 66(6):1443-1452. PubMed ID: 28533295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet abnormalities in the pathogenesis of autoimmune diabetes.
    Rosmalen JG; Leenen PJ; Pelegri C; Drexhage HA; Homo-Delarche F
    Trends Endocrinol Metab; 2002 Jul; 13(5):209-14. PubMed ID: 12185667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes: chronic progressive autoimmune disease.
    Zhang L; Gianani R; Nakayama M; Liu E; Kobayashi M; Baschal E; Yu L; Babu S; Dawson A; Johnson K; Jahromi M; Aly T; Fain P; Barker J; Rewers M; Eisenbarth GS
    Novartis Found Symp; 2008; 292():85-94; discussion 94-8, 122-9, 202-3. PubMed ID: 19203094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
    Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS
    Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
    Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
    Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus.
    Mackay IR; Bone A; Tuomi T; Elliott R; Mandel T; Karopoulos C; Rowley MJ
    J Autoimmun; 1996 Dec; 9(6):705-11. PubMed ID: 9115572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.